Home › Research › Tau biomarkers
Neurobiological studies of dementia--biological markers and neuroprotective strategies for Alzheimer disease
Tanaka T, Isoe-Wada K, Yamamori H, Kato K, Nessa BN, Sadik GM, Takeda M.. Acta neurologica Taiwanica, 2006-03-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Tau protein and amyloid s (Abeta), two major components of neuropathology in Alzheimer disease (AD), have been applied for establishment of more useful biomarkers and therapeutic approaches. Total tau protein in CSF is a biomarker for AD, however increased levels of total tau in CSF were also observed in other neurological disease with dementia. Phosphorylation is an important feature of tau protein and phosphorylated tau in CSF is useful to distinguish AD from other disease.
What this study adds
Evidence grade: Low
This paper discusses tau and amyloid as biomarkers and explores possible neuroprotective strategies for Alzheimer's disease, including a mechanism of amyloid toxicity involving down-regulation of XIAP. It is a broad biological discussion, not a clinical demonstration that any treatment, cure or prevention works in people.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Tanaka, T., Isoe-Wada, K., Yamamori, H., Kato, K., Nessa, B. N., Sadik, G. M., et al. (2006). Neurobiological studies of dementia--biological markers and neuroprotective strategies for Alzheimer disease. Acta neurologica Taiwanica.
Vancouver
Tanaka T, Isoe-Wada K, Yamamori H, Kato K, Nessa BN, Sadik GM, et al. Neurobiological studies of dementia--biological markers and neuroprotective strategies for Alzheimer disease. Acta neurologica Taiwanica. 2006. PMID: 16599295.
BibTeX
@article{tanaka2006-16599295,
author = {Tanaka, T. and Isoe-Wada, K. and Yamamori, H. and Kato, K. and Nessa, B. N. and Sadik, G. M. and Takeda, M.},
title = {{Neurobiological studies of dementia--biological markers and neuroprotective strategies for Alzheimer disease}},
journal = {Acta neurologica Taiwanica},
year = {2006},
pmid = {16599295}
}
Built from the record alzhub holds for this paper, not looked up. This record has no DOI, so the citation leaves it out. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Total tau protein in CSF is a biomarker for AD, however increased levels of total tau in CSF were also observed in other neurological disease with dementia.
- Phosphorylation is an important feature of tau protein and phosphorylated tau in CSF is useful to distinguish AD from other disease.
- Abeta has toxic effects on neuronal cells, and its mechanisms are complicated.
- One of mechanism of Abeta-cytotoxicity is a down-regulation of XIAP, and this effect is observed in the low concentration of Abeta.
Why it matters
This paper discusses tau and amyloid as biomarkers and explores possible neuroprotective strategies for Alzheimer's disease, including a mechanism of amyloid toxicity involving down-regulation of XIAP. It is a broad biological discussion, not a clinical demonstration that any treatment, cure or prevention works in people.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 27/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, so that was left out: it earned 26 of the 96 points we could judge it on, which is 27 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Acta neurologica Taiwanica) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2006 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.1 citations a year over 22 year(s) since 2006 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Masatoshi Takeda: h-index 69 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | The University of Osaka: institution h-index 1,138 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 16599295) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 26 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 26 of the 96 points we could judge it on is 27 out of 100. |
| Total | 27 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.